Paper31771237
Molecular Imaging in Pediatric Brain Tumors.
Chiaravalloti A and 4 others. Cancers (Basel), 2019. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. Molecular Imaging in Pediatric Brain Tumors. Papers, record 31771237. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31771237
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References89
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19506815 | The value of positron emission tomography and proliferation index in predicting progression in low-grade astrocytomas of childhood. | J Neurooncol | 2009 | https://conductscience.org/library/papers/19506815 | PubMed |
| 2 | 25231277 | (18)F-FET-PET guided surgical biopsy and resection in children and adolescence with brain tumors. | Childs Nerv Syst | 2015 | https://conductscience.org/library/papers/25231277 | PubMed |
| 3 | 29243585 | Review: The Role of Radiolabeled DOTA-Conjugated Peptides for Imaging and Treatment of Childhood Neuroblastoma. | Curr Radiopharm | 2018 | https://conductscience.org/library/papers/29243585 | PubMed |
| 4 | 15131035 | Somatostatin receptor subtype 2 is expressed by supratentorial primitive neuroectodermal tumors of childhood and can be targeted for somatostatin receptor imaging. | Clin Cancer Res | 2004 | https://conductscience.org/library/papers/15131035 | PubMed |
| 5 | 25854508 | Evaluation of treatment response using integrated 18F-labeled choline positron emission tomography/magnetic resonance imaging in adolescents with intracranial non-germinomatous germ cell tumours. | Pediatr Blood Cancer | 2015 | https://conductscience.org/library/papers/25854508 | PubMed |
| 6 | 29485447 | 68Ga-DOTANOC PET/CT in Medulloblastoma. | Clin Nucl Med | 2018 | https://conductscience.org/library/papers/29485447 | PubMed |
| 7 | 2193641 | Two-phase [11C]L-methionine PET in childhood brain tumors. | Pediatr Neurol | 1990 | https://conductscience.org/library/papers/2193641 | PubMed |
| 8 | 23086431 | The role of LAT1 in (18)F-DOPA uptake in malignant gliomas. | J Neurooncol | 2013 | https://conductscience.org/library/papers/23086431 | PubMed |
| 9 | 29692922 | 18F-FDOPA PET/MRI for monitoring early response to bevacizumab in children with recurrent brain tumors. | Neurooncol Pract | 2018 | https://conductscience.org/library/papers/29692922 | PubMed |
| 10 | 1438744 | Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. | Radiology | 1992 | https://conductscience.org/library/papers/1438744 | PubMed |
| 11 | 28504563 | PET Molecular Imaging-Directed Biopsy: A Review. | AJR Am J Roentgenol | 2017 | https://conductscience.org/library/papers/28504563 | PubMed |
| 12 | 17920349 | Cancer imaging with fluorine-18-labeled choline derivatives. | Semin Nucl Med | 2007 | https://conductscience.org/library/papers/17920349 | PubMed |
| 13 | 19937235 | PET imaging in pediatric neuroradiology: current and future applications. | Pediatr Radiol | 2010 | https://conductscience.org/library/papers/19937235 | PubMed |
| 14 | 28082434 | 89Zr-Bevacizumab PET: Potential Early Indicator of Everolimus Efficacy in Patients with Metastatic Renal Cell Carcinoma. | J Nucl Med | 2017 | https://conductscience.org/library/papers/28082434 | PubMed |
| 15 | 30358620 | Characterization of Diffuse Gliomas With Histone H3-G34 Mutation by MRI and Dynamic 18F-FET PET. | Clin Nucl Med | 2018 | https://conductscience.org/library/papers/30358620 | PubMed |
| 16 | 25029932 | 68Ga-DOTA-peptides in the diagnosis of NET. | PET Clin | 2014 | https://conductscience.org/library/papers/25029932 | PubMed |
| 17 | 20718912 | Pilot comparison of F-fluorocholine and F-fluorodeoxyglucose PET/CT with conventional imaging in prostate cancer. | J Med Imaging Radiat Oncol | 2010 | https://conductscience.org/library/papers/20718912 | PubMed |
| 18 | 11598490 | An energy budget for signaling in the grey matter of the brain. | J Cereb Blood Flow Metab | 2001 | https://conductscience.org/library/papers/11598490 | PubMed |
| 19 | 21233173 | Evaluation of 18F-FDG PET and MRI associations in pediatric diffuse intrinsic brain stem glioma: a report from the Pediatric Brain Tumor Consortium. | J Nucl Med | 2011 | https://conductscience.org/library/papers/21233173 | PubMed |
| 20 | 16365730 | False-positive FDG PET uptake--the role of PET/CT. | Eur Radiol | 2006 | https://conductscience.org/library/papers/16365730 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41522404 | Improving final diagnosis in paediatric posterior fossa tumours: Correlation and discrepancy between radiologic diagnosis, intraoperative surgeon's diagnosis, and histopathology. | Pak J Med Sci | 2025 | https://conductscience.org/library/papers/41522404 | PubMed |
| 40361889 | Will PET/MR Imaging Replace PET/CT for Pediatric Applications? | Diagnostics (Basel) | 2025 | https://conductscience.org/library/papers/40361889 | PubMed |
| 37370904 | Head-to-Head Comparison between FDG and 11C-Methionine in Multiple Myeloma: A Systematic Review. | Diagnostics (Basel) | 2023 | https://conductscience.org/library/papers/37370904 | PubMed |
| 36673002 | The Impact of PET/CT on Paediatric Oncology. | Diagnostics (Basel) | 2023 | https://conductscience.org/library/papers/36673002 | PubMed |
| 35512826 | PET/MRI in Pediatric Neuroimaging: Primer for Clinical Practice. | AJNR Am J Neuroradiol | 2022 | https://conductscience.org/library/papers/35512826 | PubMed |
| 35008290 | Relapsed Medulloblastoma in Pre-Irradiated Patients: Current Practice for Diagnostics and Treatment. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/35008290 | PubMed |
| 34577572 | Peptide Receptor Radionuclide Therapy and Primary Brain Tumors: An Overview. | Pharmaceuticals (Basel) | 2021 | https://conductscience.org/library/papers/34577572 | PubMed |
| 34451522 | Medical Imaging in the Diagnosis of Schistosomiasis: A Review. | Pathogens | 2021 | https://conductscience.org/library/papers/34451522 | PubMed |
| 34287265 | The Role of PET in Supratentorial and Infratentorial Pediatric Brain Tumors. | Curr Oncol | 2021 | https://conductscience.org/library/papers/34287265 | PubMed |
| 32509033 | Fluorinated phenylalanines: synthesis and pharmaceutical applications. | Beilstein J Org Chem | 2020 | https://conductscience.org/library/papers/32509033 | PubMed |
| 32481723 | Theragnostic Aspects and Radioimmunotherapy in Pediatric Tumors. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32481723 | PubMed |
Genes16
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31771237
GET https://conductscience.org/api/papers/v1/31771237/references?page=2